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M i s s i n go u t c o m ed a t ai nr a n d o m i s e dt r i a l sa r eam a j o r
potential source of bias in trial results, and their correct
handling can be a major source of difficulty for investi-
gators [1]. Missing outcome data matter for three main
reasons:
1. They lead to a loss of power. This cannot be
reversed, and so all efforts should be made to maximise
completeness of follow-up.
2. Any analysis of incomplete data makes untestable
assumptions and is likely to be biased if those assump-
tions do not hold. Because the correct assumption is
usually unknown, it is important to justify the assump-
tion used from subject-matter knowledge, and to per-
form sensitivity analyses.
3. Some popular analysis methods give inefficient esti-
mates and/or biased standard errors, even if their
assumptions are correct.
This talk will outline some of the statistical methods
available for handling missing data in randomised trials,
and what their underlying assumptions are. Some meth-
ods are simple to implement but harder to support: for
example, “Last Observation Carried Forward” is based
on an assumption that is rarely justified, while analysis
of complete cases can be statistically inefficient. More
complex methods such as mixed models and multiple
imputation are usually based around a missing at ran-
dom assumption, which is popular because it is per-
ceived to become more plausible as models become
more complex.
The intention-to-treat principle is sometimes seen as
requiring missing values to be imputed. By focussing
instead on assumptions, I will show that it is sufficient
for all observed data to be included in the main analysis,
but that sensitivity analyses must take account of all
randomised individuals. This approach will be sum-
marised in an intention-to-treat analysis strategy [2].
I will also briefly describe how to perform a sensitivity
analysis and how to handle missing baseline variables.
Published: 13 December 2011
References
1. National Research Council: The prevention and treatment of missing data
in clinical trials. The National Academies Press; Washington, DC; 2010
[http://www.nap.edu/catalog.php?record_id=12955].
2. White IR, Horton N, Carpenter J, Pocock SJ: Strategy for intention to treat
analysis in randomised trials with missing outcome data. British Medical
Journal 2011, 342:d40[http://www.bmj.com/content/342/bmj.d40].
doi:10.1186/1745-6215-12-S1-A59
Cite this article as: White: Strategies for handling missing data in
randomised trials. Trials 2011 12(Suppl 1):A59.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Correspondence: ian.white@mrc-bsu.cam.ac.uk
MRC Biostatistics Unit, Cambridge CB2 0SR, UK
White Trials 2011, 12(Suppl 1):A59
http://www.trialsjournal.com/content/12/S1/A59 TRIALS
© 2011 White; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.